GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AMC-109 | LTX 109 | LTX-109 | Lytixar®
Compound class:
Synthetic organic
Comment: Voxvoganan is the clinical lead from a series of synthetic antimicrobial peptidomimetics (SAMPs) with Gram-positive and Gram-negative antibacterial activity [1-2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12025 | voxvoganan |
Synonyms ![]() |
| AMC-109 | LTX 109 | LTX-109 | Lytixar® |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
LTX-109 |
| Other databases | |
| CAS Registry No. | 1166254-80-3 (source: Scifinder) |
| ChEBI | CHEBI:77752 |
| ChEMBL Ligand | CHEMBL1817968 |
| DrugBank Ligand | DB12711 |
| GtoPdb PubChem SID | 507750392 |
| PubChem CID | 25242323 |
| Search Google for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |
| Search Google for chemicals with the same backbone | ZVOYWSKEBVVLGW |
| Search PubMed clinical trials | voxvoganan |
| Search PubMed titles | voxvoganan |
| Search PubMed titles/abstracts | voxvoganan |
| UniChem Compound Search for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZVOYWSKEBVVLGW-ZDCRTTOTSA-N |